Regulation & Policy
FDA-approved epilepsy drug may help reverse osteoarthritis damage
Summary: Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain.
Key points
- Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain.
- The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.